Se connecter

Bibliographies thématiques / Antibodies / Articles de revues

Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Antibodies.

Articles de revues sur le sujet « Antibodies »

Auteur : Grafiati

Publié le 4 juin 2021

Mis à jour le 25 juillet 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Antibodies ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.

1

Deora, Kanika, and Ruchee Khanna. "Clinical Profile of the Patients with Antiphospholipid Antibodies: Lupus Anticoagulant and Anticardiolipin Antibodies." Indian Journal of Forensic Medicine and Pathology 12, no. 3 (2019): 195–99. http://dx.doi.org/10.21088/ijfmp.0974.3383.12319.6.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

2

Chiswell, David J., and John McCaffery. "Phage antibodies: will new ‘coliclonal’ antibodies replace monoclonal antibodies?" Trends in Biotechnology 10 (1992): 80–84. http://dx.doi.org/10.1016/0167-7799(92)90178-x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

3

Pooja, Tiwari Patel Pratixa Mishra Satyam Yadav Rubi. "An Extensive Review Study Of Solely Cloned Identical Antibodies - Monoclonal Antibodies." International Journal in Pharmaceutical Sciences 1, no. 12 (2023): 21–34. https://doi.org/10.5281/zenodo.10251264.

Texte intégral

Résumé :

Since they were developed, monoclonal antibodies have been studied for potential therapeutic use. The forefront of modern medicine's move towards a new era of individualized therapy is the use of monoclonal antibodies to treat a range of ailments. Monoclonal antibodies can be employed for therapeutic, imaging, and diagnostic applications and have a very high clinical significance. Monoclonal antibodies have a variety of intriguing potential clinical uses. Because the monoclonal antibodies used were either produced in mice or rats, there is currently a risk of disease transfer from mice to peop

Styles APA, Harvard, Vancouver, ISO, etc.

4

Linhardt, Robert J., C. W. Abell, R. M. Denney, et al. "Monoclonal antibodies and immobilized antibodies." Applied Biochemistry and Biotechnology 15, no. 1 (1987): 53–80. http://dx.doi.org/10.1007/bf02798506.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

5

Favoreel, Herman W., Geert Van Minnebruggen, Gerlinde R. Van de Walle, Jolanta Ficinska, and Hans J. Nauwynck. "Herpesvirus interference with virus-specific antibodies: Bridging antibodies, internalizing antibodies, and hiding from antibodies." Veterinary Microbiology 113, no. 3-4 (2006): 257–63. http://dx.doi.org/10.1016/j.vetmic.2005.11.003.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

Clark, A. "Antibodies." Journal of Clinical Pathology 42, no. 5 (1989): 559. http://dx.doi.org/10.1136/jcp.42.5.559-c.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

7

Bradbury, Andrew, Nileena Velappan, Vittorio Verzillo, et al. "Antibodies in proteomics I: generating antibodies." Trends in Biotechnology 21, no. 6 (2003): 275–81. http://dx.doi.org/10.1016/s0167-7799(03)00112-4.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

Kounis, Nicholas G., George D. Soufras, and George N. Kounis. "Antibodies against antibodies inducing Kounis syndrome." International Journal of Cardiology 168, no. 5 (2013): 4804–5. http://dx.doi.org/10.1016/j.ijcard.2013.07.037.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

9

Trier, Nicole, Paul Hansen, and Gunnar Houen. "Peptides, Antibodies, Peptide Antibodies and More." International Journal of Molecular Sciences 20, no. 24 (2019): 6289. http://dx.doi.org/10.3390/ijms20246289.

Texte intégral

Résumé :

The applications of peptides and antibodies to multiple targets have emerged as powerful tools in research, diagnostics, vaccine development, and therapeutics. Antibodies are unique since they, in theory, can be directed to any desired target, which illustrates their versatile nature and broad spectrum of use as illustrated by numerous applications of peptide antibodies. In recent years, due to the inherent limitations such as size and physical properties of antibodies, it has been attempted to generate new molecular compounds with equally high specificity and affinity, albeit with relatively

Styles APA, Harvard, Vancouver, ISO, etc.

10

Matraszek, Veronika Viktoria, Hynek Heřman, and Ilona Hromadníková. "The relevance of antiphospholipid antibodies in obstetrics." Česká gynekologie 89, no. 3 (2024): 237–44. http://dx.doi.org/10.48095/cccg2024237.

Texte intégral

Résumé :

Summary: Aim and methodology: To provide a comprehensive review on new findings and current recommendations regarding antiphospholipid antibodies with particular emphasis on clinical impact on gestation. Conclusion: Antiphospholipid antibodies are an important risk factor for the development of a series of pregnancy-related complications. Early diagnosis and appropriate therapy can reduce the incidence of pregnancy loss and pregnancy-related complications. Key words: antiphospholipid antibodies – antiphospholipid syndrome – lupus anticoagulant – anticardiolipin antibodies – anti-ß2-glycoprotei

Styles APA, Harvard, Vancouver, ISO, etc.

11

Qian, J., Y. Xing, D. Yufang, et al. "OP0216 THE CLINICAL AND PATHOLOGICAL ROLES OF AUTOANTIBODIES TARGETING BMP SIGNALING IN SYSTEMIC LUPUS ERYTHEMATOSUS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 141.1–142. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3682.

Texte intégral

Résumé :

BackgroundPulmonary arterial hypertension (PAH) is one of the most severe complications and the leading cause of death in patients with systemic lupus erythematosus (SLE). Pathogenic mechanisms leading to SLE-PAH are still not fully understood. In idiopathic PAH, the dysfunction of the bone morphogenetic protein (BMP) pathway was found to be involved in pulmonary artery remodeling [1]. In SLE-PAH, our previous study identified serum autoantibodies targeting BMP receptors (BMPR) as the potential biomarker, including anti-BMPR2, BMPR1A, and Activin Receptor-Like Kinase type 1 (ALK1) antibodies [

Styles APA, Harvard, Vancouver, ISO, etc.

12

Khan, Ramsha, Melissa Menard, Chao-Ching Jen, Xi Chen, Peter A. A. Norris, and Alan H. Lazarus. "Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP." Blood 135, no. 26 (2020): 2420–24. http://dx.doi.org/10.1182/blood.2019003646.

Texte intégral

Résumé :

Abstract Polyclonal anti-D is a first-line therapy for immune thrombocytopenia (ITP). Monoclonal antibodies are desirable alternatives, but none have yet proven successful despite their ability to opsonize erythrocytes (or red blood cells, RBCs) and cause anemia. Here, we examined 12 murine erythrocyte–specific antibodies of different specificity and subtypes and found that 8 of these antibodies could induce anemia in antigen-positive mice. Of these 8 antibodies, only 5 ameliorated ITP. All antibodies were examined for their in vitro ability to support macrophage-mediated phagocytosis of eryth

Styles APA, Harvard, Vancouver, ISO, etc.

13

Reddy, Raghuram, Joel Mintz, Roei Golan, et al. "Antibody Diversity in Cancer: Translational Implications and Beyond." Vaccines 10, no. 8 (2022): 1165. http://dx.doi.org/10.3390/vaccines10081165.

Texte intégral

Résumé :

Patients with cancer tend to develop antibodies to autologous proteins. This phenomenon has been observed across multiple cancer types, including bladder, lung, colon, prostate, and melanoma. These antibodies potentially arise due to induced inflammation or an increase in self-antigens. Studies focusing on antibody diversity are particularly attractive for their diagnostic value considering antibodies are present at an early diseased stage, serum samples are relatively easy to obtain, and the prevalence of antibodies is high even when the target antigen is minimally expressed. Conversely, the

Styles APA, Harvard, Vancouver, ISO, etc.

14

Rathod, PG1* Singh VK1 and Parasana DK2. "Immunochemical techniques: An Overview." Science World a monthly e magazine 2, no. 12 (2022): 2024–31. https://doi.org/10.5281/zenodo.7414424.

Texte intégral

Résumé :

Immunochemical techniques are based on a reaction of antigen with antibody, or more exactly, on a reaction of an antigenic determinants with the binding site of the antibody. The antibodies used are produced by various ways. Monoclonal antibodies are products of a single clone of plasma cells derived from B-lymphocytes, prepared in the laboratory by hybridoma technology, based on cellular fusion of tumor (myeloma) cells with splenic lymphocytes of immunized mice. Monoclonal antibodies are directed against single epitope; and are all identical copies of immunoglobulin molecule with the same pri

Styles APA, Harvard, Vancouver, ISO, etc.

15

Shoenfeld, Yehuda. "The idiotypic network in autoimmunity: antibodies that bind antibodies that bind antibodies." Nature Medicine 10, no. 1 (2004): 17–18. http://dx.doi.org/10.1038/nm0104-17.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

16

Bobrovnik, S. A., M. O. Demchenko, and S. V. Komisarenko. "Effect of trifluoroethanol on antibodies binding properties." Ukrainian Biochemical Journal 95, no. 1 (2023): 20–30. http://dx.doi.org/10.15407/ubj95.01.020.

Texte intégral

Résumé :

The studies on the influence of organic co-solvents on the structure and function of antibodies are of key interest, especially in view of antibodies broad use as recognizing elements in different analytical systems. Here we studied the effect of co-solvent 2,2,2-trifluoroethanol (TFE) on the ability of anti-ovalbumin monoclonal antibodies to interact with its specific antigen. Antibody affinity to antigen and the rate constants of antibody binding to immobilized antigen were analyzed. Changes in antibody reactivity with incubation time which depended on TFE concentration and temperature were

Styles APA, Harvard, Vancouver, ISO, etc.

17

Dahl, Mark V., and Alina G. Bridges. "Intravenous immune globulin: Fighting antibodies with antibodies." Journal of the American Academy of Dermatology 45, no. 5 (2001): 775–83. http://dx.doi.org/10.1067/mjd.2001.119085.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

18

SHITARA, Kenya. "Potelligent Antibodies as Next Generation Therapeutic Antibodies." YAKUGAKU ZASSHI 129, no. 1 (2009): 3–9. http://dx.doi.org/10.1248/yakushi.129.3.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

19

Methe, H. "Antibodies Stop Secretion of Antibodies in Lupus." Science Translational Medicine 4, no. 141 (2012): 141ec115. http://dx.doi.org/10.1126/scitranslmed.3004529.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

20

Filatova, Elena A., Grigory B. Krapivinsky, Grigory N. Filatov, Alisa V. Lazareva, and Evgeny E. Fesenko. "Antiidiotypic antibodies against anti-cGMP polyclonal antibodies." Biochimica et Biophysica Acta (BBA) - Biomembranes 1064, no. 2 (1991): 293–96. http://dx.doi.org/10.1016/0005-2736(91)90314-x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

21

Nikita, Sapkal Ritesh Rathod* Sakshi Lande Pallavi Radal Haridas Khose. "Monoclonal Antibodies: Insight Review." International Journal of Pharmaceutical Sciences 2, no. 12 (2024): 249–64. https://doi.org/10.5281/zenodo.14265260.

Texte intégral

Résumé :

Monoclonal antibodies (mAbs) are a significant achievement in biotechnology and medicine. Kohler and Milstein's Nobel Prize-winning research on murine hybridoma technology in 1975 resulted in the development of mAbs, which are designed to function as substitute antibodies that can restore, augment, or mimic the immune system's attack on cancer cells and other infections. In 1986, the FDA approved the first monoclonal antibody, Orthoclone OKT3® (muromonab-CD3), a huge step forward in antibody research and development. Monoclonal antibodies are glycoproteins produced by identical B cell clon

Styles APA, Harvard, Vancouver, ISO, etc.

22

Heng, Boon Chin, Wenjin Huang, Xiufang Zhong, Ping Yin, and Guo Qing Tong. "Roles of Antiphospholipid Antibodies, Antithyroid Antibodies and Antisperm Antibodies in Female Reproductive Health." Integrative Medicine International 2, no. 1-2 (2015): 21–31. http://dx.doi.org/10.1159/000381900.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

23

BYGREN, P., N. RASMUSSEN, B. ISAKSSON, and J. WIESLANDER. "Anti-neutrophil cytoplasm antibodies, anti-GBM antibodies and anti-dsDNA antibodies in glomerulonephritis." European Journal of Clinical Investigation 22, no. 12 (1992): 783–92. http://dx.doi.org/10.1111/j.1365-2362.1992.tb01447.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

24

Van de Perre, Philippe, Penny L. Moore, Nicolas Nagot, Lucio Gama, and Jean-Pierre Moles. "Broadly neutralizing antibodies, nonneutralizing antibodies and broadly effector antibodies to prevent HIV transmission?" AIDS 39, no. 7 (2025): 918–20. https://doi.org/10.1097/qad.0000000000004115.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

25

Kapustianenko, L. G. "POLYCLONAL ANTIBODIES AGAINST HUMAN PLASMINOGEN KRINGLE 5." Biotechnologia Acta 10, no. 3 (2017): 41–49. http://dx.doi.org/10.15407/biotech10.03.041.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

26

Yatsenko, T. A. "POLYCLONAL ANTIBODIES AGAINST HUMAN PLASMINOGEN: PURIFICATION, CHARACTERIZATION AND APPLICATION." Biotechnologia Acta 13, no. 6 (2020): 50–57. http://dx.doi.org/10.15407/biotech13.06.050.

Texte intégral

Résumé :

The plasminogen/plasmin system plays a crucial role in fibrinolysis and regulation of cell functions in a wide range of normal and pathological processes. Investigation of plasminogen/plasmin functions requires the availability of well-characterized and effective molecular tools, such as antibodies. In the present work, the isolation and characterization of rabbit polyclonal antibodies against human plasminogen are described and approaches for the identification of plasminogen and its fragments using the purified antibodies are demonstrated. For the antibodies isolation, standard animal immuni

Styles APA, Harvard, Vancouver, ISO, etc.

27

Triplett, Douglas A. "Antiphospholipid Antibodies." Archives of Pathology & Laboratory Medicine 126, no. 11 (2002): 1424–29. http://dx.doi.org/10.5858/2002-126-1424-aa.

Texte intégral

Résumé :

Abstract Objective.—To review the role of lupus anticoagulants in the pathogenesis of both venous and arterial thromboembolic events, as well as in recurrent spontaneous abortions. The pathophysiology of lupus anticoagulants and associated antiphospholipid antibodies (eg, anticardiolipin antibodies) is also discussed. Data Sources.—Review of the recent medical literature. Data Extraction and Synthesis.—Key articles in the recent medical literature dealing with lupus anticoagulants and their role in pathogenesis of thromboembolic events were reviewed. Plasma proteins that have an affinity for b

Styles APA, Harvard, Vancouver, ISO, etc.

28

Brinkmann, Ulrich, and Roland E. Kontermann. "Bispecific antibodies." Science 372, no. 6545 (2021): 916–17. http://dx.doi.org/10.1126/science.abg1209.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

29

Rieger, Paula Trahan. "Monoclonal Antibodies." American Journal of Nursing 87, no. 4 (1987): 469. http://dx.doi.org/10.2307/3470440.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

30

Groner, Bernd, Cord Hartmann, and Winfried Wels. "Therapeutic Antibodies." Current Molecular Medicine 4, no. 5 (2004): 539–47. http://dx.doi.org/10.2174/1566524043360483.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

31

Kosmas, C., H. Kalofonos, and A. A. Epenetos. "Monoclonal Antibodies." Drugs 38, no. 5 (1989): 645–57. http://dx.doi.org/10.2165/00003495-198938050-00001.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

32

Larrick, James W., and Kirk E. Fry. "Recombinant antibodies." Human Antibodies 2, no. 4 (1991): 172–89. http://dx.doi.org/10.3233/hab-1991-2401.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

33

Bronson, Richard A. "Sperm Antibodies." Immunology and Allergy Clinics of North America 10, no. 1 (1990): 165–84. http://dx.doi.org/10.1016/s0889-8561(22)00256-9.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

34

Pisetsky, David S. "ANTINUCLEAR ANTIBODIES." Immunology and Allergy Clinics of North America 14, no. 2 (1994): 371–85. http://dx.doi.org/10.1016/s0889-8561(22)00780-9.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

35

Smith, J. Bruce, and F. Susan Cowchock. "ANTIPHOSPHOLIPID ANTIBODIES." Immunology and Allergy Clinics of North America 14, no. 4 (1994): 821–34. http://dx.doi.org/10.1016/s0889-8561(22)00345-9.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

36

Pratt, Donna E. "THYROID ANTIBODIES." Immunology and Allergy Clinics of North America 14, no. 4 (1994): 835–38. http://dx.doi.org/10.1016/s0889-8561(22)00346-0.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

37

Visan, Ioana. "Enhancing antibodies." Nature Immunology 22, no. 7 (2021): 800. http://dx.doi.org/10.1038/s41590-021-00973-7.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

38

Khamashta, Munther A., and Graham R. V. Hughes. "Antiphospholipid antibodies." Clinical Reviews in Allergy 12, no. 3 (1994): 287–96. http://dx.doi.org/10.1007/bf02802323.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

39

Adair, J., and A. Lawson. "Therapeutic Antibodies." Drug Design Reviews - Online 2, no. 3 (2005): 209–17. http://dx.doi.org/10.2174/1567269053828800.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

40

Pullen, Richard L. "Antinuclear antibodies." Nursing Made Incredibly Easy! 20, no. 6 (2022): 47–48. http://dx.doi.org/10.1097/01.nme.0000884112.83689.31.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

41

Santos-Argumedo, Leopoldo. "Natural Antibodies." Advances in Neuroimmune Biology 3, no. 3,4 (2012): 345–52. http://dx.doi.org/10.3233/nib-012912.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

42

&NA;. "Monoclonal antibodies." Reactions Weekly &NA;, no. 1293 (2010): 36. http://dx.doi.org/10.2165/00128415-201012930-00100.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

43

Hudson, Peter J., and Christelle Souriau. "Engineered antibodies." Nature Medicine 9, no. 1 (2003): 129–34. http://dx.doi.org/10.1038/nm0103-129.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

44

Benkovic, Stephen J. "Catalytic Antibodies." Annual Review of Biochemistry 61, no. 1 (1992): 29–54. http://dx.doi.org/10.1146/annurev.bi.61.070192.000333.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

45

Harris, E. Nigel. "ANTIPHOSPHOLIPID ANTIBODIES." British Journal of Haematology 74, no. 1 (2008): 1–9. http://dx.doi.org/10.1111/j.1365-2141.1988.00491.x-i1.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

46

Harris, E. Nigel. "ANTIPHOSPHOLIPID ANTIBODIES." British Journal of Haematology 74, no. 1 (1990): 1–9. http://dx.doi.org/10.1111/j.1365-2141.1990.tb02530.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

47

Drlicek, M., U. Liszka, W. Grisold, A. Mohn-Staudner, F. Lintner, and K. Jellinger. "Antineuronal antibodies." Neurology 40, no. 11 (1990): 1804. http://dx.doi.org/10.1212/wnl.40.11.1804-b.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

48

Helmerhorst, F. M., M. J. J. Finken, and J. J. Erwich. "Antisperm antibodies." Human Reproduction 14, no. 7 (1999): 1669–71. http://dx.doi.org/10.1093/humrep/14.7.1669.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

49

Worland, PhD, Peter J., Gary S. Gray, PhD, Mark Rolfe, PhD, Karen Gray, PhD, and Jeffrey S. Ross, MD. "Anticancer Antibodies." American Journal of Clinical Pathology 119, no. 4 (2003): 472–85. http://dx.doi.org/10.1309/y6lp-c0lr-726l-9dx9.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

50

Ross, Jeffrey S., Karen Gray, Gary S. Gray, Peter J. Worland, and Mark Rolfe. "Anticancer Antibodies." American Journal of Clinical Pathology 119, no. 4 (2003): 472–85. http://dx.doi.org/10.1309/y6lpc0lr726l9dx9.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!